首页> The Journal of Infectious Diseases> Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

导出原文传递

翻译打印收藏纠错

第一作者： Reichman RC

作者： Reichman RC ^[1] ; Morse GD ; Demeter LM ; Resnick L ; Bassiakos Y ; Fischl M ; Para M ; Powderly W ; Leedom J ; Greisberger C ; al.

作者单位： Department of Medicine, University of Rochester School of Medicine & Dentistry, NY 14642. ^[1]

关键词 Antiviral Agents HIV Infections HIV-1 Piperazines Zidovudine Reverse Transcriptase Inhibitors 抗病毒药 HIV感染哌嗪类齐多夫定

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of Infectious Diseases

1995年171卷2期

297-304页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

The Journal of Infectious Diseases

1995年171卷2期

297-304页

检索历史清除

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

The Journal of Infectious Diseases

相似文献

同项目论文

The Journal of Infectious Diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

The Journal of Infectious Diseases

相似文献

同项目论文

The Journal of Infectious Diseases

相关期刊

检索历史清除